Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2
Analytical Biochemistry · 2023-04 · 666 · 115079
DOI: 10.1016/j.ab.2023.115079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2023-04. Verfasst von Hamidreza Yadegari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Tehran University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND AND AIMS: The coronavirus disease 2019 (COVID-19) pandemic is a serious health problem worldwide. Early virus detection is essential for disease control and management. Viral antigen detection by ELISA is a cost-effective, rapid, and accurate antigen diagnostic assay which could facilitate early viral detection. METHOD: An antigen-capture sandwich ELISA was developed using novel nucleocapsid (NP)-specific mouse monoclonal antibodies (MAbs). The clinical performance of the assay was assessed using 403 positive and 150 negative respiratory samples collected during different SARS-CoV-2 variants outbreaks in Iran. RESULTS: The limit of detection of our ELISA assay was found to be 43.3 pg/ml for recombinant NP. The overall sensitivity and specificity of this assay were 70.72% (95% CI: 66.01-75.12) and 100% (95% CI: 97.57-100), respectively, regardless of Ct values and SARS-CoV-2 variants. There was no significant difference in our assay sensitivity for the detection of Omicron subvariants compared to Delta variant. Assay sensitivity for the BA.5 Omicron subvariant was calculated as 91.89% (95% CI: 85.17-96.23) for samples with Ct values < 25 and 82.70% (95% CI: 75.19-88.71) for samples with Ct values < 30. CONCLUSION: Our newly developed ELISA method is reasonably sensitive and highly specific for detection of SARS-CoV-2 regardless of the variants and subvariants of the virus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Monoclonal Antibody Research Center, Avicenna Research Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.
- Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m_amiri@tums.ac.ir.
- Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: fshokri@tums.ac.ir.
Förderung
- Tehran University of Medical Sciences
Zitieren
APA
Yadegari, H., Mohammadi, M., Maghsood, F., Ghorbani, A., Bahadori, T., Golsaz-Shirazi, F., Zarnani, A. H., Salimi, V., Jeddi-Tehrani, M., Amiri, M. M., & Shokri, F. (2023). Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2. Analytical Biochemistry, 666, 115079. https://doi.org/10.1016/j.ab.2023.115079
Vancouver
Yadegari H, Mohammadi M, Maghsood F, Ghorbani A, Bahadori T, Golsaz-Shirazi F, et al. Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2. Analytical Biochemistry. 2023;666:115079. doi:10.1016/j.ab.2023.115079
BibTeX
@article{Yadegari2023,
author = {Yadegari, Hamidreza and Mohammadi, Mehdi and Maghsood, Faezeh and Ghorbani, Ahmad and Bahadori, Tannaz and Golsaz-Shirazi, Forough and Zarnani, Amir-Hassan and Salimi, Vahid and Jeddi-Tehrani, Mahmood and Amiri, Mohammad Mehdi and Shokri, Fazel},
title = {Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2},
journal = {Analytical Biochemistry},
year = {2023},
volume = {666},
pages = {115079},
doi = {10.1016/j.ab.2023.115079}
}
EUVIMED